دکتر مجید فدایی
نوشته شده برای وبلاگ پزشکان طب سوزنی ایران
تجربه نشان داده است که آلرژی های فصلی را میتوان به راحتی با دانه گذاری گوش ( نوعی طب فشاری گوش ) در کودکان و بزرگسالان کنترل و درمان کرد . اول مهر و شروع مدارس ,معمولا هم زمان با افزایش عفونتهای دستگاه تنفسی از قبیل گلودرد و سرما خوردگی در کودکان با پیش زمینه آلرژی , همراه میباشد. درمان یا کاهش آلرژی با طب فشاری گوش میتواند به این بیماران و خانواده آنها بسیار کمک کند . مقاله طب فشاری گوش که در یکی از دانشگاه های استرالیا انجام و در ژورنال آلرژی بینی امریکا چاپ شده است بیانگر این مطلب میباشد.
Ear acupressure for perennial allergic rhinitis: A multicenter randomized controlled trial.
- 1Traditional & Complementary Medicine Research Program, Health Innovations Research Institute, School of Health Sciences, Royal Melbourne Institute of Technology University, Victoria, Australia.
Perennial allergic rhinitis (PAR) has a high and increasing prevalence worldwide. Ear acupressure (EAP) is a noninvasive semi-self-administered form of acupuncture. Previous studies indicated that EAP could be effective and safe for AR symptom management. However, there was insufficient evidence to confirm this. This study investigated whether EAP, a noninvasive clinical alternative toacupuncture, is effective and safe for PAR.
This is an international, multicenter, randomized, single-blind, sham-controlled trial. The trial was conducted at two centers: Royal Melbourne Institute of Technology University (Melbourne, Australia) Clinical Trial Clinic and Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China. PAR participants were randomized to receive real or sham EAP treatment once a week for 8 weeks and then were followed-up for 12 weeks. Participants were instructed to administer EAP stimulation three times daily. Symptom severity and quality of life (QoL) were evaluated. Adverse events (AEs) were also monitored. Intention-to-treat analysis on change of symptom scores and QoL was applied.
Two hundred forty-five participants were randomly assigned to real (n = 124) and sham EAP (n = 121) groups. Twenty-five participants discontinued during treatment and 15 participants dropped out during follow-up. At the end of treatment and follow-up periods, changes of global QoL score were significantly greater in the real EAP group compared with the sham group. At the end of follow-up, scores for total nasal symptom, runny nose, and eye symptoms in the real EAP group had a greater reduction compared with the sham group. Overall, both real and sham EAP were well tolerated. Two severe AEs were reported but were not considered related to the EAP procedures.
In conclusion, EAP showed short-term and extended benefit for improving PAR symptoms and QoL for PAR patients.